Minimum Wear Duration for the activPALTM Professional Activity Monitor in Adolescent Females by Dowd, Kieran P. et al.
1 
Title: Minimum Wear Duration for the activPAL
TM
 Professional Activity Monitor in Adolescent 1 
Females. 2 
Running Head: Minimum activPAL Wear Time 3 
Competing Interests: The authors declare no conflict of interest.  4 
2 
Abstract: 5 
Objectives: This study aims to determine the minimum number of days of monitoring required to reliably predict 6 
sitting/lying time, standing time, light intensity physical activity (LIPA), moderate-to-vigorous intensity physical 7 
activity (MVPA) and steps in adolescent females. 8 
Methods: 195 adolescent females (mean age=15.7 years; SD=0.9) participated in the study. Participants wore the 9 
activPAL activity monitor for a seven day protocol. The amount of time spent sitting/lying, standing, in LIPA and 10 
in MVPA and the number of steps per day were quantified. Spearman-Brown Prophecy formulae were used to 11 
predict the number of days of data required to achieve an intraclass correlation coefficient of both 0.7 and 0.8. 12 
Results: For the percentage of the waking day spent sitting/lying, standing, in LIPA and in MVPA, a minimum of 9 13 
days of accelerometer recording is required to achieve a reliability of ≥0.7, while a minimum of 15 days is required 14 
to achieve a reliability of ≥0.8. For steps, a minimum of 12 days of recording is required to achieve a reliability of 15 
≥0.7, with 21 days to achieve a reliability of ≥0.8. 16 
Conclusion: Future research in adolescent females should collect a minimum of 9 days of accelerometer data to 17 
reliably estimate sitting/lying time, standing time, LIPA and MVPA, while 12 days is required to reliably estimate 18 
steps. 19 
Keywords: activPAL, Minimum, Adolescent, Wear Time, Physical Activity, Sedentary Behaviour.  20 
3 
Introduction: 21 
The elimination of physical inactivity has the potential to reduce the incidence of major non-22 
communicable diseases by 6-10% (12). Increasing the prevalence of individuals achieving the 23 
recommended daily amount of moderate-to-vigorous physical activity (MVPA) is a key behaviour to 24 
target when addressing the prevalence of non-communicable disease (12). Furthermore, evidence has 25 
accumulated on the deleterious effects of sedentary behaviours (SB) on health outcomes (23). 26 
Consequently, reducing the amount of time spent sedentary is becoming an increasingly important 27 
component of public health recommendation development globally (24). 28 
Accurate and reliable measures of physical behaviours (including sitting/lying time (SLT), standing 29 
time (StT), light intensity physical activity (LIPA) and MVPA) in free-living environments are 30 
essential when identifying associations between specific physical behaviours and health outcomes, 31 
identifying determinants that may influence participation in physical behaviours, informing 32 
interventions that target specific physical behaviours, and evaluating the effectiveness of interventions 33 
and improving public health surveillance (28). The selection of which measure to employ is often a 34 
trade-off between feasibility and validity in field-based research (26, 30). Reviews of the literature 35 
have highlighted the advantages and disadvantages of a wide range of field-based measures of 36 
physical activity (PA) and SB (26, 30, 31). These reviews suggest that motion sensors, such as 37 
accelerometers, are currently the measure of choice (26, 31). 38 
Free-living activity behaviours across given monitoring periods are characterised by large amounts of 39 
inter-individual and intra-individual variability (15), which can significantly impact measurement 40 
reliability. Reliability is a prerequisite to validity and the reliability of a device must be determined to 41 
ensure valid estimates of free-living physical behaviours (3). By determining the inter- and intra-42 
individual variability across days of measurement, researchers can define the number of days of 43 
monitoring required to reliably estimate such behaviours. The minimum number of days required to 44 
assess PA and SB with a suitable level of reliability vary substantially across age, population and 45 
accelerometer (27). In young children, highly variable findings have been observed, with research 46 
suggesting that between 2-7 days of accelerometer wear time provide a reliable estimate of total PA 47 
4 
and SB (1, 9). There is also debate in relation to the necessity of the inclusion of weekend data for the 48 
reliable estimation of typical activity in young children (8, 18). In adults, it has been recommended 49 
that a minimum of seven consecutive days of accelerometry wear time is required for a reliable 50 
estimate of time spent inactive and in MVPA (13), while any 3 days of measurement is appropriate 51 
for examining steps per day (29). 52 
When establishing the minimum number of days required to reliably estimate sedentary time, 53 
researchers have historically relied on devices that require count-to-activity thresholds to estimate 54 
sedentariness. A count-to-activity threshold is a threshold that relates arbitrary accelerometer count 55 
values to an estimate of energy expenditure. The most typical sedentary threshold utilised is that for 56 
the ActiGraph, whereby <100 accelerometers counts per minute signifies sedentary time. The use of 57 
sedentary thresholds relies on the lack of ambulation to estimate SB rather than examining the 58 
postural allocation of the individual (11, 17). Such estimates may under/over-estimate sedentary time 59 
due to the inclusion of standing or low ambulatory activities (11, 17). Device developments have 60 
enabled the examination of postural allocation to accurately distinguish between SLT and StT, and 61 
have been encouraged over count-to-activity thresholds (17). One such device, the activPAL
TM
 (PAL 62 
Technologies Ltd, Glasgow, UK), has previously been identified as a valid measure of SLT in 63 
children (19) and adults (11) and as a measure of MVPA in adolescent females (6). 64 
To the author’s knowledge, the minimum number of days of monitoring required when examining 65 
free-living SLT, StT, LIPA, MVPA and steps when using the activPAL in an adolescent population 66 
has not been defined. The purpose of this study was to determine the number of days of activPAL 67 
monitoring required to reliably estimate SLT, StT, LIPA, MVPA and steps in an adolescent female 68 
sample.  69 
5 
Methods: 70 
Data were collected from a cross-sectional sample of students from 13 schools in the mid-western 71 
region of Ireland between 2009 and 2011. Participants were randomly selected from all 13-18 year old 72 
female students in each school. To be eligible for inclusion, participants were required to have no 73 
injuries or illnesses which impact their participation in PA. Written informed participant and parental 74 
consent were obtained prior to data collection. All procedures were reviewed and approved by the 75 
researchers institute research ethics committee. Data collection on all participants was completed 76 
during school term, meaning all data on weekdays presented were schooldays. 77 
Objective examination of physical behaviours over a seven day period was obtained using the 78 
activPAL. The activPAL is a thigh mounted accelerometer-based activity monitor, measuring 79 
53×35×7mm and weighing 20g. The activPAL samples at 10 Hz and measures bodily accelerations 80 
using a uni-axial accelerometer (5). The monitor provides information on whether the wearer is in a 81 
sitting/lying position, standing position or if the wearer is stepping, while activity counts and step 82 
counts are also provided. The monitor communicates with a Windows (Microsoft Corporation, One 83 
Microsoft Way, Redmond, WA, USA) compatible PC via a USB interface. All monitors were 84 
initialised on the morning of distribution to each participant. The activPAL was worn on the midpoint 85 
of the anterior aspect of the right thigh and was attached to the skin using a hydro-gel adhesive pad 86 
(PALstickie
TM
). Monitors were distributed to the participants by the investigators, while every student 87 
was provided with detailed instructions on how the monitor was to be worn. Participants were then 88 
asked to attach the device as instructed. Finally, investigators examined the location of attachment to 89 
ensure that the monitor was worn appropriately. Participants were instructed to wear the device at all 90 
times (24 hour wear protocol), and to only remove the device when bathing or for water-based 91 
activities. Participants were supplied with extra PALstickie
TM
 to reapply the device if it was removed. 92 
The device was worn for a seven day wear protocol. At the end of data collection, the devices were 93 
collected by investigators, and the activPAL data was downloaded to the same PC via USB interface. 94 
Prior to detailed examination of accelerometer data, all activPAL output was visually inspected using 95 
the activPAL software to identify potential erroneous data from monitor malfunction, prolonged 96 
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periods of non-wear time and to identify the earliest and latest time the monitor registered movement 97 
over a typical 24 hour measurement period. To determine the number of valid days of accelerometry 98 
required to reliably estimate SLT, StT, LIPA and MVPA, a criteria for a valid measurement day was 99 
defined. A valid measurement day was classified as a day with <4 hours of non-wear time during 100 
waking hours (defined below) (5). Non-wear time was defined as a period with ≥60 minutes of 101 
consecutive zero activity counts (25). The non-wear periods for each day were summed, and all 102 
measurement days with ≥4 hours of non-wear time during waking hours were removed from this 103 
analysis. For all remaining participants, the daily non-wear time was summed, and the non-wear time 104 
was subtracted from both the waking day time and the sitting/lying time to ensure that only wear 105 
periods were included for analysis. 106 
All components of PA and SB were presented as a percentage of waking hours (5). The amount of 107 
waking time was calculated as waking hours = bed time - rise time. To estimate the number of bed 108 
hours, the first registered non-sedentary epoch after 7:00 a.m. was identified as rise time. This time 109 
was chosen as no participant was identified to have risen from bed prior to 7:00 a.m. during visual 110 
inspection of the data. The last registered non-sedentary epoch, which was followed by an 111 
uninterrupted sedentary period (>2 hours), was identified as the time the participants went to bed (5). 112 
The activPAL was used to estimate daily SLT, StT, LIPA, MVPA and steps. A detailed description of 113 
the methodologies applied to examine the activPAL output for these physical behaviours has 114 
previously been provided (5, 6). Briefly, SLT was defined as all time spent in a sitting/lying posture 115 
during a waking day. Standing time was defined as time spent in a standing position with no stepping 116 
(i.e. standing still), and was calculated by summing the total number of seconds spent standing. LIPA 117 
was defined as all time spent in stepping at an intensity of <3 metabolic equivalents (METs) (e.g. slow 118 
walking, household chores, etc.), while MVPA was defined as all time spent stepping at an intensity 119 
of >3 METs. For MVPA, a threshold of 2997 counts per epoch (15 s) was used to estimate METs for 120 
each 15s period, where MVPA was defined as >3 METs (6). Steps were determined from the 121 
activPAL output, and were summed over the measured day to provide steps per day. Sitting/lying time 122 
was adjusted by subtracting non-wear time from SLT. This method of examining non-wear time data 123 
7 
was completed as 1) non-wear time would otherwise be categorised as SLT and 2) no records for the 124 
types of activity completed during non-wear time were collected. Total wear time during the waking 125 
day was calculated by subtracting non-wear time from the identified waking measurement period. 126 
Finally, SLT, StT, LIPA and MVPA were then presented as a percentage of the total wear time during 127 
the waking day. 128 
Descriptive statistics are presented as mean (SD), median (25th percentile, 75th percentile) or number 129 
(percentage) as appropriate. All numeric data were assessed for skewness by visual inspection of 130 
histograms and formal tests of normality. The distributions of the sedentary and PA variables were 131 
found to be skewed so Box-Cox transformations were used to transform the data to normality prior to 132 
analyses. Linear mixed models (LMM) were used to model the transformed daily data, accounting for 133 
the different number of days of recorded data across the sample. Single day intraclass correlations 134 
(ICC) values were computed from the LMM models, where the ICC is defined as the ratio of 135 
between-individual variance to the sum of the between- and within- individual variance. The 136 
reliability of the activPAL daily measurements of physical behaviours and steps was assessed using 137 
the Spearman-Brown prophecy formula (22). The number of required days to reach the target average 138 
ICC was computed using the Spearman-Brown prophecy formula: N=ICCT(1-ICCS)/(ICCS(1-ICCT)), 139 
where ICCs=single day ICC, N=number of required days and ICCT=target average measures ICC. 140 
Although an average measures ICC (computed as the ICC of an average measure across N days) of 141 
≥0.8 has been identified as an acceptable level of reliability (2), an ICC of ≥0.7 has been suggested as 142 
being appropriate as it reduces the amount of data excluded and maximizes power (14). In this study, 143 
the number of required days were computed separately for ICCT=0.8 and ICCT=0.7. Statistical 144 
analyses were conducted using IBM SPSS Statistics version 21.0 (Cary, NC).  145 
8 
Results: 146 
Of those randomly selected, a total of 216 students (76%) agreed to take part in the study. Due to 147 
malfunctioning devices, 21 datasets were excluded from analysis. A total of 195 valid datasets were 148 
included. No differences existed between excluded and included participants for age, height, weight 149 
or BMI. Participants mean age was 15.7 (±0.9) years, with a median BMI of 21.7 (IQR = 5.2) kg/m
2
. 150 
Nine participants (4.6%) were classified as underweight, 132 participants (67.7%) had normal weight, 151 
41 participants (21.0%) were overweight, and 13 participants (6.7%) were obese. A total of 29 152 
participants provided 4 days of accelerometer data (14.9%), 140 provided 5 valid days (71.8%) and 26 153 
providing 6 valid days (13.3%). A total of 180 participants provided data on both weekend days 154 
(92.3%), with 15 participants providing data on one weekend day only (7.7%). 155 
Descriptive information on the amount of waking time spent (hrs.) in SLT, StT, LIPA and MVPA 156 
across days of the week is provided in Table 1. The percentage of the waking day spent in these 157 
behaviours, along with the number of steps accumulated across each day of the week, are also 158 
presented in Table 1. Daily waking hours across the measured week ranged from 12.8 (IQR=1.2) on 159 
Sundays to 16.2 (IQR=1.8) on Fridays.  160 
The Spearman-Brown Prophecy Formulae based on ICCs for all collected data with a reliability of 0.7 161 
and 0.8 were used to predict the number of days of complete data needed to reliably predict SLT, StT, 162 
LIPA, MVPA and steps. The results of the Spearman Brown Prophecy Formulae are presented in 163 
Table 2. For a reliability of 0.7, a minimum of 9 days of activPAL monitoring are required to reliably 164 
estimate SLT, StT, LIPA and MVPA. A minimum of 15 days of activPAL monitoring are required to 165 
achieve a reliability of 0.8 for all activity intensity variables. For steps, a minimum of 12 days of 166 
recording is required to give a reliability of 0.7, while 21 days of measurement are required to provide 167 
a reliability of 0.8. 168 
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Table 1: Descriptive characteristics of i) the total number of waking hours, ii) the number of waking hours spent sitting/lying, standing, in light intensity 169 
physical activity and in moderate to vigorous intensity physical activity, iii) the percentage of waking time spent sitting/lying, standing, in light intensity 170 
physical activity and in moderate to vigorous intensity physical activity and iv) the number of steps per day across days of the week. 171 
 
Monday 
(n = 171) 
Tuesday 
(n = 140) 
Wednesday 
(n = 139) 
Thursday 
(n = 63) 
Friday 
(n = 84) 
Saturday 
(n = 188) 
Sunday 
(n = 184) 
Waking Hours 15.4 
(14.8, 16.0) 
15.0 
(14.3, 15.6) 
15.2 
(14.5, 15.8) 
15.2 
(14.7, 15.8) 
16.2 
(15.2, 17.0) 
14.5 
(13.2, 15.5) 
12.8 
(11.8, 14.0)
 
Sitting/Lying (hrs.) 10.3 
(9.1, 11.2) 
9.8 
(8.8, 11.0) 
10.0 
(8.7, 11.1) 
9.2 
(8.2, 11.0) 
10.4 
(9.4, 11.8) 
9.2 
(7.8, 10.7) 
8.6 
(7.2, 9.8) 
Standing (hrs.) 3.3  
(2.7, 3.9) 
3.3  
(2.5, 3.9) 
3.3  
(2.6, 4.1) 
3.8  
(2.8, 4.4) 
3.4  
(2.6, 4.4) 
3.3  
(2.4, 4.4) 
2.8 
(2.0, 3.5) 
LIPA (hrs.) 0.76  
(0.63, .97) 
0.77  
(0.64, .96) 
0.78  
(0.65, 1.00) 
0.78  
(0.63, 1.08) 
0.84  
(0.65, 1.09) 
0.80  
(0.55, 1.03) 
0.65 
(0.49, 0.85) 
MVPA (hrs.) 0.80  0.91  0.83  1.06  0.85  0.72  0.44 
10 
(0.58, 1.25) (0.61, 1.29) (0.55, 1.27) (0.83, 1.34) (0.50, 1.38) (0.37, 1.11) (0.23, 0.91) 
% Waking hrs        
Sitting/Lying (%) 67.1  
(60.8, 72.8) 
66.1  
(60.0, 72.5) 
66.8  
(59.7, 73.4) 
61.9  
(55.3, 72.1) 
65.6  
(58.8, 73.7) 
64.4  
(54.9, 74.4) 
68.4  
(58.6, 75.9) 
Standing (%) 21.7  
(17.7, 25.9) 
21.6  
(17.2, 26.9) 
21.6  
(18.1, 26.8) 
24.0  
(18.7, 30.1) 
21.9  
(16.8, 26.9) 
23.0  
(17.4, 30.3) 
21.9  
(16.1, 27.7) 
LIPA (%) 5.0  
(4.1, 6.4) 
5.1  
(4.3, 6.4) 
5.2  
(4.3, 6.4) 
5.1  
(4.0, 7.3) 
5.5  
(4.3, 6.8) 
5.6  
(4.0, 7.1) 
5.2  
(3.9, 6.7) 
MVPA (%) 5.3  
(3.9, 8.0) 
6.3  
(4.1, 8.5) 
5.5  
(3.7, 8.5) 
6.6  
(5.3, 8.9) 
5.5  
(3.2, 8.1) 
4.9  
(2.6, 7.7) 
3.4  
(1.8, 7.2) 
Steps 8364 
(6428, 11263) 
8539 
(6408, 11625) 
8824 
(6312, 10922) 
9994 
(7898, 11888) 
9122 
(6512, 13113) 
8010 
(4724, 10978) 
5261 
(3540, 8644) 
All data presented as median (25
th
 percentile, 75
th
 percentile) due to non-normality of data. 172 
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Table 2: Number of days of complete data required to estimate components of waking sitting/lying, 173 
standing, light and moderate-to-vigorous intensity physical activity and steps per day from the 174 
activPAL activity monitor in adolescent females. 175 
Behaviours Target Reliability Value (ICC) 
 0.7 0.8 
Sitting/Lying Time (% Waking) 6.9 days 11.8 days 
Standing Time (% Waking) 5.7 days 9.8 days 
Light Intensity Physical Activity (% Waking) 5.2 days 9.0 days 
Moderate-to-Vigorous Physical Activity (% Waking) 8.8 days 15.1 days 
Steps  12.1 days 20.8 days 
  176 
12 
Discussion: 177 
This study aimed to determine the number of days of activPAL monitoring required to reliably 178 
examine SLT, StT, LIPA, MVPA and steps in a sample of adolescent females. As far as the authors 179 
are aware, this is the first study to examine the reliability of objective measurement of free-living SB, 180 
based on posture rather than sedentary thresholds (i.e. less than ActiGraph 100 counts-per-minute), in 181 
an adolescent cohort. The findings of the present study suggest that a minimum of seven days of 182 
activPAL measurement is required to achieve a reliability coefficient of ≥0.7 for measurement of 183 
SLT, StT and LIPA, while at least 12 days of data are required for a coefficient of ≥0.8. Where the 184 
activPAL acceleration data are also used to quantify MVPA, 9 days of activPAL measurement are 185 
required to achieve a reliability coefficient of ≥0.7, while at least 15 days of measurement were 186 
required to achieve a reliability coefficient of ≥0.8 in this sample. 187 
When examining physical behaviours in free-living environments, it is essential that sufficient data 188 
are gathered to ensure a reliable estimate of these variables is obtained (3, 27). Researchers have 189 
examined the minimum number of days of accelerometer measurement required to achieve acceptable 190 
reliability of free-living accelerometer output, focusing on the examination of daily accelerometer 191 
counts (7, 9), MVPA (1, 8, 13, 28) or step count (7, 29). However, limited information is available for 192 
the minimum number of days required to provide reliable estimates of SLT, StT and LIPA. It is 193 
becoming apparent that these behaviours at the lower end of the activity intensity continuum may play 194 
a significant role in energy balance and the prevention of risk factors for major non-communicable 195 
disease (21, 23). In order to strengthen the evidence of the associations between such health variables 196 
and SLT, StT and LIPA, it is necessary to ensure that sufficient data to provide reliable estimates is 197 
obtained. In adolescent females, a minimum of 9 days of SLT, StT, LIPA and MVPA are required to 198 
achieve an acceptable level of reliability. Interestingly, larger day to day variability in MVPA 199 
compared to the other behaviours of interest was evident, with it requiring 8.8 days of measurement to 200 
achieve a reliability of ≥0.7 (compared to 5.2, 5.7 and 6.9 for LIPA, StT and SLT respectively). 201 
Future research should aim to increase the number of measured days to a minimum of 9 consecutive 202 
13 
days of accelerometer measurement, moving away from the commonly employed 4 days including 1 203 
weekend day (4, 10). 204 
As this is the first study to assess the minimum number of days required to reliably predict SLT, StT, 205 
LIPA using the activPAL in adolescent females, it is difficult to directly compare these findings with 206 
existing literature. However, the findings for the minimum number of days required to reliably predict 207 
MVPA are comparable to other studies utilising objective measures. In a study of 30 children aged 7-208 
15 years, Janz et al. identified that a minimum of 6 days of accelerometer recording was necessary to 209 
achieve a reliability coefficient of ≥0.8 when estimating the amount of time spent sedentary and in 210 
MVPA (10). Similarly, in an analysis of 436 female adolescents (mean age = 14.1 years (SD = 0.45)), 211 
the minimum recommended wear duration to reliably predict minutes spent in MVPA was 6 days 212 
(16). Trost et al. identified that a 7 day monitoring protocol was recommended when examining the 213 
reliability of MVPA in a combined cohort of children and adolescents (28). However, notable 214 
differences in the variability of activity behaviours were observed between children and adolescents 215 
when examined separately, with a minimum of 4-5 days of recording recommended for children and 216 
8-9 days recommended for adolescents (28). Discrepancies in the minimum number of days 217 
recommended in the current paper compared to existing literature is likely due to differences in 218 
activity monitor used (i.e. CSA/ActiGraph vs activPAL), activity monitor wear location (thigh versus 219 
hip/wrist), activity monitor protocol differences (i.e. 24 hour wear protocol compared to waking wear 220 
protocol for other devices), potential sample differences (i.e. age, sex, environmental and cultural 221 
differences) and data reduction methodologies (i.e. treadmill versus non-treadmill-based MVPA 222 
count-to-activity thresholds). 223 
A significant strength of this study is the examination of objectively determined SLT and StT using 224 
the “gold standard” objective measurement device, the activPAL (11). The use of this device enables 225 
the differentiation of StT from LIPA, while an estimate of time spent in MVPA is also possible. As 226 
far as the authors are aware, this is the first study to examine the minimum number of days of 227 
measurement required to achieve acceptable reliability for each of these behaviours, rather than 228 
relying on estimates of sedentary time from count-to-activity thresholds that do not distinguish 229 
14 
between sitting and standing. This study provides some of the first evidence on the minimum number 230 
of days of activPAL measurement for a reliable estimate of SLT in this population. Additionally, the 231 
relatively large sample size of adolescent females (n=195) was a strength of the study. 232 
The limitations of this study must be acknowledged. Although accelerometers are the preferred 233 
objective measure of habitual physical behaviours (26, 31), lower limb worn devices like the 234 
activPAL have their own limitations, including the inability to measure arm movements (i.e. window 235 
cleaning, ironing etc.) and some specific activities (i.e. stair climbing, cycling, swimming etc.) (30). 236 
Due to the age and sex specific sample, it is not possible to generalise the findings of this study to 237 
other populations, as the calculated ICC values are constrained to the sample from which they are 238 
calculated (2). Additionally, newer generation activPAL monitors (i.e. the triaxial activPAL3
TM
) have 239 
been developed, and output from different generation devices may not be comparable due to software 240 
and hardware upgrades. However, generally good agreement for postural position between 241 
generations of activPAL devices have previously been reported, suggesting that the minimum number 242 
of days of monitoring reported here for postural position may be applicable to newer generation 243 
devices (20).   244 
15 
Conclusion: 245 
The findings of this study suggest that a minimum of 7 valid days of recording is required to achieve a 246 
reliability of ≥0.7 for activPAL derived SLT, StT and LIPA in individuals, while a minimum of 9 247 
days is required for a reliable estimate of MVPA for individuals in an adolescent female population. 248 
This measurement period ensures that all days of the week are recorded, reducing the risk of bias due 249 
to any potential differences in waking hours or waking behaviours on this day. Future research should 250 
examine the minimum number of days required to achieve acceptable levels of reliability for activity 251 
intensities at the lower end of the activity intensity continuum in children, adults and older adults to 252 
help strengthen associations made between such activity behaviours and health.  253 
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